3,5-二氯-6-甲基-1,4-噁唑-2-酮 | 125849-94-7

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机卤素化合物 - 芳基卤化物
• 中文名称: 3,5-二氯-6-甲基-1,4-噁唑-2-酮
• 中文别名: 3,5-二氯-6-甲基-1,4-恶嗪-2-酮
• 英文名称: 3,5-dichloro-6-methyl-2(H)-1,4-oxazin-2-one
• 英文别名: 3,5-dichloro-6-methyl-1,4-oxazin-2-one；6-methyl-3,5-dichloro-2H-1,4-oxazin-2-one；3,5-dichloro-6-methyl-2H-1,4-oxazin-2-one
• CAS: 125849-94-7
• 化学式: C₅H₃Cl₂NO₂
• mdl: MFCD11110701
• 分子量: 179.99
• InChiKey: IQINLHFBRNSNIE-UHFFFAOYSA-N

物化性质

• 熔点：
  70 °C
• 沸点：
  212℃
• 密度：
  1.62
• 闪点：
  82℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  38.7
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  3,5-二氯-6-甲基-1,4-噁唑-2-酮 在 palladium on activated charcoal 三乙烯二胺 、 盐酸 、 4-二甲氨基吡啶 、 氢气 作用下， 以 乙酸乙酯 、 甲苯 为溶剂， 20.0~110.0 ℃ 、303.98 kPa 条件下， 反应 18.0h， 生成 4-(1-acetyl-1H-indol-3-yl)-1-methyl-2-oxa-5-azabicyclo[2.2.2]octan-3-one
  参考文献：
  名称：

  Stereoselective conversion of 2 H -1,4-oxazin-2-ones into 2,5,5-substituted piperidine-2-carboxamides and 2-methanamines and related octahydro-2 H -pyrido[1,2- a ]pyrazines, potential substance P antagonists

  摘要：

  4-(Hetero)aryl-2-oxa-5-azabicyclo[2.2.2] octan-3-ones and 3,6-diones, formed via cycloaddition of 2H-1,4-oxazin-2-ones and ethene followed by functional group transformation, undergo lactone cleavage by reaction with amines to yield substituted 2-(hetero)aryl-5-hydroxy-2-piperidinecarboxamides. Subsequent reduction affords the corresponding 2-piperidinemethanamines. Both amide and amine compounds are of interest as potential Substance P antagonists. A detailed NMR study, supported by conformational calculations, of an octahydro-2H-pyrido[1,2-a]pyrazine analogue revealed the existence of a temperature and solvent dependent equilibrium mixture of transoid and cisoid invertomers. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(01)00888-2
• 作为产物：
  描述：

  乳腈 在 草酰氯 、 三乙胺盐酸盐 作用下， 以 氯苯 为溶剂， 生成 3,5-二氯-6-甲基-1,4-噁唑-2-酮
  参考文献：
  名称：

  [EN] 6,5-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
  [FR] MODULATEURS ALLOSTÉRIQUES D'ÉTHER D'HÉTÉROARYLE PIPÉRIDINE 6,5-FUSIONNÉS DU RÉCEPTEUR MUSCARINIQUE DE L'ACÉTYLCHOLINE M4

  摘要：

  本发明涉及6,5-融合杂环哌啶醚化合物，这些化合物是M4肌氨酸乙酰胆碱受体的变构调节剂。本发明还涉及所述化合物在潜在的治疗或预防神经系统和精神疾病中的用途，这些疾病和疾病中涉及M4肌氨酸乙酰胆碱受体。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗涉及M4肌氨酸乙酰胆碱受体的疾病中的用途。

  公开号：

  WO2018118736A1

文献信息

• 6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDIN-5-ONE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
  申请人：BAO JIANMING

  公开号：US20170183342A1

  公开（公告）日：2017-06-29

  The present invention is directed to 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine-5-one compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

  本发明涉及6,7-二氢-5H-吡咯[3,4-b]吡啶-5-酮化合物，这些化合物是M4毒蕈碱乙酰胆碱受体的变构调节剂。本发明还涉及在本申请中描述的化合物在潜在治疗或预防神经和精神障碍和疾病中的应用，其中涉及M4毒蕈碱乙酰胆碱受体。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在预防或治疗涉及M4毒蕈碱乙酰胆碱受体的疾病的应用。
• [EN] 2,4'-BIPYRIDINYL COMPOUNDS AS PROTEIN KINASE D INHIBITORS USEFUL FOR THE TREATMENT OF IA HEART FAILURE AND CANCER<br/>[FR] COMPOSÉS DE 2,4'-BIPYRIDINYLE COMME INHIBITEURS DE LA PROTÉINE KINASE D UTILES POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE ET DU CANCER
  申请人：NOVARTIS AG

  公开号：WO2009150230A1

  公开（公告）日：2009-12-17

  The present invention provides novel organic compounds of Formula I: methods of use, and pharmaceutical compositions thereof.

  本发明提供了式I的新型有机化合物：其使用方法和药物组合物。
• Diels-Alder reactions of pyridine o-quinodimethane analogues generated from functionalised o-bis(chloromethyl)pyridines
  作者：Peter R. Carly、Steven L. Cappelle、Frans Compernolle、Georges J. Hoornaert

  DOI：10.1016/0040-4020(96)00680-1

  日期：1996.9

  2,3- and 3,4-o-bis(chloromethyl)pyridines 3, produced via cycloaddition of the oxazinones 2 with propargyl chloride and 1,4-dichloro-2-butyne, were used as precursors of various pyridine o-quinodimethane analogues. The 2,3- and 3,4-dimethylenepyridine systems were generated via reductive 1,4-elimination with iodide and trapped in situ with various dienophiles to form the tetrahydroquinoline and -isoquinoline

  通过恶唑酮2与炔丙基氯和1,4-二氯-2-丁炔的环加成反应制得的多官能2,3-和3,4-邻-双（氯甲基）吡啶3用作各种吡啶邻-的前体。喹二甲烷类似物。2，3-和3，4-二亚甲基吡啶体系是通过用碘化物进行的1，4-还原消除而产生的，并用各种亲二烯体原位捕获以形成四氢喹啉和-异喹啉型加合物。与与丙烯酸甲酯的反应相反，在3,4-二亚甲基吡啶体系中，富含电子的亲二烯体，即二氢呋喃和乙基乙烯基醚，具有区域特异性的环加成反应。
• Functionalized o-bis(chloromethyl)pyridines as precursors for pyridine o-quinodimethane analogues and their [4+2] cycloadducts
  作者：Peter R. Carly、Frans Compernolle、Georges J. Hoornaert

  DOI：10.1016/0040-4039(95)00169-d

  日期：1995.3

  From oxazinones 4, precursors for pyridine o-quinodimethane analogues are made accessible via cycloaddition with 1,4-dichloro-2-butyne and propargyl chloride. Subsequent 1,4-elimination of the polyfunctional o-bis(chloromethyl)-pyridines affords both 2,3- and 3,4-dimethylene compounds, which are trapped in situ with various dienophiles.

  通过1,4-二氯-2-丁炔和炔丙基氯的环加成反应，可从恶嗪酮4中获得吡啶邻喹啉甲烷类似物的前体。随后的多官能邻-双（氯甲基）-吡啶的1，4-消除提供了2，3-和3，4-二亚甲基化合物，它们被各种双亲亲烯剂原位捕获。
• [EN] HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR<br/>[FR] MODULATEURS ALLOSTÉRIQUES D'ÉTHER DE PIPÉRIDINE D'HÉTÉROARYLE DU RÉCEPTEUR DE L'ACÉTYLCHOLINE MUSCARINIQUE M4
  申请人：MERCK SHARP & DOHME

  公开号：WO2018118734A1

  公开（公告）日：2018-06-28

  The present invention is directed to heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

  本发明涉及异芳基哌啶醚化合物，其为M4肌氨酸乙酰胆碱受体的变构调节剂。本发明还涉及所述化合物在潜在的治疗或预防M4肌氨酸乙酰胆碱受体参与的神经和精神障碍和疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗M4肌氨酸乙酰胆碱受体参与的疾病中的用途。